# Mitochondrial Nicotinic Acetylcholine Receptors Support Liver Cells Viability After Partial Hepatectomy

Kateryna Uspenska, Olena Lykhmus, Maria Obolenskaya, Stéphanie Pons, Uwe Maskos, Serhiy Komisarenko, Maryna Skok

► To cite this version:

Kateryna Uspenska, Olena Lykhmus, Maria Obolenskaya, Stéphanie Pons, Uwe Maskos, et al.. Mitochondrial Nicotinic Acetylcholine Receptors Support Liver Cells Viability After Partial Hepatectomy. Frontiers in Pharmacology, 2018, 9, pp.626. 10.3389/fphar.2018.00626. hal-02888329

HAL Id: hal-02888329

https://hal.science/hal-02888329

Submitted on 3 Jul 2020

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

Check for
updates

# Mitochondrial Nicotinic Acetylcholine Receptors Support Liver Cells Viability After Partial Hepatectomy

Kateryna Uspenska<fnref n="1" />, Olena Lykhmus<fnref n="1" />, Maria Obolenskaya², Stephanie Pons³, Uwe Maskos³, Serhiy Komisarenko<fnref n="1" /> and Maryna Skok<fnref n="1" />*

Nicotinic acetylcholine receptors (nAChRs) expressed on the cell plasma membrane are ligand-gated ion channels mediating fast synaptic transmission, regulating neurotransmitter and cytokine release and supporting the viability of many cell types. The nAChRs expressed in mitochondria regulate the release of pro-apoptotic factors, like cytochrome c, in ion channel-independent manner. Here we show that α3β2, α7β2, and α9α10 nAChR subtypes are up-regulated in rat liver mitochondria 3–6 h after partial hepatectomy resulting in increased sustainability of mitochondria to apoptogenic effects of Ca²⁺ and H₂O₂. In contrast, laparotomy resulted in down-regulation of all nAChR subunits, except α9, and decreased mitochondria sustainability to apoptogenic effects of Ca²⁺ and H₂O₂. Experiments performed in liver mitochondria from α3+/−, α7−/−, β4−/−, α7β2−/−, or wild-type C57Bl/6J mice demonstrated that the decrease of α3 or absence of α7 or α7/β2 subunits in mitochondria is compensated with β4 and α9 subunits, which could be found in α3β4, α4β4, α9β4, and α9α10 combinations. Mitochondria from knockout mice maintained their sustainability to Ca²⁺ but were differently regulated by nAChR subtype-specific ligands: PNU-282987, methyllycaconitine, dihydro-β-erythroidine, α-conotoxin MII, and α-conotoxin PeIA. It is concluded that mitochondrial nAChRs play an important role in supporting the viability of hepatic cells and, therefore, may be a pharmacological target for pro-survival therapy. The concerted action of multiple nAChR subtypes controlling either CaMKII- or Src-dependent signaling pathways in mitochondria ensures a reliable protection against apoptogenic factors of different nature.

**Keywords:** nicotinic acetylcholine receptor, mitochondria, knockout mice, partial hepatectomy, cytochrome c, mitochondrial kinases

## INTRODUCTION

Nicotinic acetylcholine receptors are ligand-gated ion channels initially discovered in neuro-muscular synapses and further found in neurons and in many non-excitable cells (Skok, 2002; Kalamida et al., 2007; Kawashima and Fujii, 2008; Gotti et al., 2009). The classical idea on the nAChR involvement in fast synaptic transmission has evolved along with the understanding of universal and evolutionary ancient kind of acetylcholine signaling in the living nature (Wessler and Kirkpatrick, 2008). Now it is clear that acetylcholine and its receptors

**Abbreviations:** CaMKII, calcium-calmodulin-dependent kinase; cyt c, cytochrome c; DhβE, dihydro-β-erythroidine; LT, laparotomy; MLA, methyllycaconitine; nAChR, nicotinic acetylcholine receptor; PHE, partial hepatectomy.

**OPEN ACCESS**

**Edited by:**
Domenico Tricarico,
Università degli Studi di Bari Aldo Moro, Italy

**Reviewed by:**
Antonio R. Artalejo,
Complutense University of Madrid,
Spain
Madeline Nieves-Cintron,
University of California, Davis,
United States

*Correspondence:
Maryna Skok
skok@biochem.kiev.ua

**Specialty section:**
This article was submitted to Pharmacology of Ion Channels and Channelopathies, a section of the journal Frontiers in Pharmacology

**Received:** 03 April 2018
**Accepted:** 24 May 2018
**Published:** 13 June 2018

**Citation:** Uspenska K, Lykhmus O, Obolenskaya M, Pons S, Maskos U, Komisarenko S and Skok M (2018) Mitochondrial Nicotinic Acetylcholine Receptors Support Liver Cells Viability After Partial Hepatectomy. *Front. Pharmacol.* 9:626. doi: 10.3389/fphar.2018.00626

<footnote n="1">¹ Laboratory of Cell Receptors Immunology, O. V. Palladin Institute of Biochemistry, Kiev, Ukraine, ² System Biology Group, Institute of Molecular Biology and Genetics, Kiev, Ukraine, ³ Integrative Neurobiology of Cholinergic Systems, Institut Pasteur, Paris, France</footnote>
(both nicotinic and muscarinic) appeared in evolution long
before the development of nerve and muscle systems and were
initially intended to regulate the vital functions of primitive cells
like survival, proliferation and adhesion (Kawashima and Fujii,
2008). The prototypes of nAChRs were found in bacteria where
they respond to the changes in the environmental pH (Bocquet
et al., 2007).

Structurally, the nAChRs are homo- or hetero-pentamers composed of established combinations of ten α (α1 to α10) and four β (β1 to β4) subunits; muscular nAChRs contain 2α1, β1, γ and δ or ε subunits (Kalamida et al., 2007). Binding of agonist results in concerted conformational movement of the subunits within the pentamer leading to ion channel opening (gating) (Changeux, 2012). However, certain kinds of nAChR signaling, especially in non-excitable cells, seem not to require gating as such and are, therefore, ion-independent (Skok, 2009). Probably, this is the most ancient type of cholinergic signaling not related to significant changes in the cell membrane polarity.

The important step in the understanding of the universal
character of cholinergic signaling was the discovery of functional
nAChRs in mitochondria (Gergalova et al., 2012). Previously, we
reported that several nAChR subtypes are found in the outer
membrane of mouse mitochondria in a tissue-specific manner
and in close relation to voltage-dependent anion channels
(VDACs) (Gergalova et al., 2012; Lykhmus et al., 2014). The
function of mitochondrial nAChRs appeared to be ion channel-
independent, because they engage intramitochondrial kinases
under the effect of agonists, antagonists and even positive
allosteric modulators (Gergalova et al., 2014; Uspenska et al.,
2017). The main function of mitochondrial nAChRs known
by now is to regulate the early stages of mitochondria-driven
apoptosis like cyt c release (reviewed in Skok et al., 2016).
In contrast, nicotine effects on mitochondria respiratory chain
appeared to be receptor-independent (Cormier et al., 2001). The
nAChRs found in the brain mitochondria are modulated by
inflammation (Lykhmus et al., 2016) and influence accumulation
of amyloid peptides (1-40)/(1-42) in an experimental model of
Alzheimer-like pathology in mice (Lykhmus et al., 2015). Others
have shown that malignant cell transformation is accompanied
by the increase of mitochondrial nAChR number (Grando, 2014),
that was related to increased viability of cancer cells. However, the
real value of cholinergic signaling in mitochondria is still far from
being completely understood.

In the present study, we used two experimental models: rats
subjected to PHE and knockout mice lacking certain nAChR
subunits. The first model demonstrated the role of mitochondrial
nAChRs in supporting the cell viability during the priming phase
of liver regeneration. The second model allowed us to reveal
compensatory mechanisms occurring in the absence of certain
mitochondrial nAChR subtypes.

## MATERIALS AND METHODS

### Materials

All reagents were of chemical grade and were purchased from
Sigma-Aldrich (Saint Louis, United States), unless specially

indicated. Antibodies against α7(1–208) (Lykhmus et al., 2010), α3(181–192), α4(181–192), α7(179–190) (Skok et al., 1999), α9(11–23) (Koval et al., 2011), β2(190–200) or β4(190–200) (Koval et al., 2004) nAChR fragments were obtained and characterized previously in our lab. Antibody against α10(404–417) (Lips et al., 2002) was a kind gift of Dr. W. Kummer (Justus Liebig University Giessen, Giessen, Germany). The antibodies were biotinylated according to standard procedure (Harlow and Lane, 1988). Rabbit cyt c-specific antibodies were generated as previously described (Gergalova et al., 2014). Conotoxin MII, synthesized according to Surin et al. (2012) and α-conotoxin PeIA, synthesized as described (Koval et al., 2011) was a kind gift of Prof. V. Tsetlin (Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, RAS, Russia). Dexalgin (analog of Dexketoprofen, (2S)-2-[3-(benzoyl)phenyl]propanoic acid) was purchased from the public drugstore in Kiev.

### Animals and Procedures

Animals were kept in the animal facilities of Institut Pasteur, Paris, France and O. V. Palladin Institute of Biochemistry, Kiev, Ukraine. They were housed in quiet, temperature-controlled rooms and provided with water and food pellets *ad libitum*. All procedures conformed with the guidelines of the Center National de la Recherche Scientifique or Palladin Institute's IACUC. Before starting the experiments, the protocols were approved by the IACUC.

Age-matched C57BL/6J wild-type (WT) and knockout mice lacking either α7 (Orr-Urtreger et al., 1997), α7 and β2 or β4 (Xu et al., 1999b) nAChR subunits, 20–22 g, of both genders were used. Since homozygous α3—/— mice do not survive (Xu et al., 1999a), heterozygous α3+/— mice were used instead. Before removing the liver mice were sacrificed by cervical dislocation.

Male Wistar rats (200–250 g) were operated under ether
anesthesia according to standard procedures (Higgins and
Anderson, 1931; Tannuri et al., 2007). The animal's abdomen was
opened carefully. In PHE, medial and left lateral liver lobes were
resected and further used as controls compared to regenerating
liver. Then the abdomen was closed with a single-layer running
suture. In LT, no liver parts were removed and the abdomen
was closed similarly to PHE. Following surgery, the operated
animals obtained a single intramuscular injection of dexalgin
(0.33 mg/kg), they were returned to their cages and fed regular
diets and water *ad libitum*. The animals were sacrificed by
decapitation under ether anesthesia 3, 6, 12, or 24 hours after the
operation.

### Mitochondria Purification

Mitochondria were isolated from rodent liver by differential ultracentrifugation according to standard published procedures (Sottocasa et al., 1967; Gergalova et al., 2012). In brief, the liver was homogenized in the separation medium containing 10 mM HEPES, 1 mM EGTA, and 250 mM sucrose, pH 7.4, 4°C. The primary homogenate was centrifuged at 1,500 × g at 4°C for 10 min, the pellet being considered as non-mitochondrial fraction. The supernatant containing mitochondria was centrifuged at 8,000 × g at 4°C for 10 min and the pellet was washed by additional centrifugation at similar conditions.
The purity of mitochondria and mitochondria-depleted fractions was assessed by ELISA using the antibodies against nuclear-specific lamin B1, mitochondria-specific VDAC or endoplasmic reticulum-specific IRE-1α as described (Uspenska et al., 2017). The purified live mitochondria were used for functional cyt c release studies. To prepare detergent lysates, the pellets of both fractions were frozen at -20°C, thawed and treated with lysing buffer (0.01 M Tris-HCl, pH 8.0; 0.14 NaCl; 0.025% NaN₃; 1% Tween-20 and protease inhibitors cocktail) for 2 h on ice upon intensive stirring. The resulting lysates were pelleted by centrifugation (20 min at 20,000 × g). The protein concentration was established by using the BCA Protein Assay kit (Thermo Fisher Scientific, Rockford, United States).

## Cytochrome c Release Studies

The purified live mitochondria were incubated with different concentrations of CaCl₂ or 0.5 mM H₂O₂ in the presence or absence of various nAChR ligands at room temperature (RT), for 5 min, and immediately pelleted by centrifugation (10 min, 7,000 × g at 4°C). The incubation medium contained 10 mM HEPES, 125 mM KCl, 25mM NaCl, 5 mM sodium succinate, and 0.1 mM Pi(K), pH 7.4. The nAChR ligands: PNU-282987 (30 nM), MLA (50 nM), DhβE (1 µM), α-conotoxin MII (1 nM), and α-conotoxin PeIA (2.5, 5, and 25 nM) were added to the incubation medium 2 min prior to the apoptogenic agents. The mitochondria supernatants were collected and tested for the presence of cyt c by sandwich assay as described (Gergalova et al., 2012, 2014). Experimental values of OD₄₀₀ nm were within the linear part of the calibration curve built with bovine cyt c.

## Sandwich Assays

To determine the type of nAChR subunits in mitochondria and mitochondria-depleted fractions, 96-well plates (Nunc Maxisorb, Roskilde, Denmark) were coated with α7(1-208)-specific antibody (30 µg/ml at 4°C, overnight), subsequently blocked with 1% BSA/PBS, and the detergent lysates of the corresponding fractions (100 µg/ml) were applied into coated wells for 2 h at 37°C. Then, the plates were rinsed with water and the bound antigen was revealed with biotinylated α3(181-192)-, α4(181-192)-, α7(179-190)-, α9(11-23)-, α10(404-417)-, β2(190-200), or β4(190-200)-specific antibodies applied for additional 2 h, followed by NeutrAvidin-peroxidase conjugate and o-phenylendiamine-containing substrate solution. The Stat-Fax2100 Microplate reader (Awareness Technology, Inc., FL, United States) was used to determine the optical density of the samples at 490 nm absorbance (OD490 nm). All antibodies have been preliminary titrated on corresponding antigenic peptides and the doses (dilutions) have been selected according to titration curves: 1:200 for α3-specific, 1:80 for α4-specific, 1:300 for α7-specific, 1:250 for α9-specific, 1:250 for α10-specific, 1:500 for β2-specific, and 1:200 for β4-specific, assuming that the initial concentration of all antibodies was 2 mg/ml.

To determine the nAChR subunit combinations, the plates were coated with α3-, α4-, α9-, α10- or β4-specific antibody (30 µg/ml) and the bound nAChRs from mitochondria detergent lysate were revealed with biotinylated α9(11-23)- or β4(190-200)-specific antibodies similarly to procedure described above.

## Statistical Analysis

We used five mice per genotype in experiments with knockout mice and three rats per time point in PHE and LT experiments. All ELISAs were performed in triplicates and the average values for each mouse or rat were used to calculate means and SE. Statistical analysis was performed using Student's t-test; the difference was considered significant at *p* < 0.05.

## RESULTS

### Mitochondrial nAChRs Are Involved in Liver Regeneration After PHE

Partial hepatectomy is a unique experimental model enabling to investigate the early events of tissue regeneration. It provides relevant and individual controls, the parts of liver resected in the course of surgery, to be compared with the remaining parts undergoing regeneration for various periods of time. Additional control is provided by the control surgery, LT, which allows excluding the effects of skin damage, anesthesia and inflammation also present during hepatectomy. In our experiments, to minimize the number of animals used, we at first performed a time-dependent study using one animal per time point and then added more rats for the most important time points (3 and 6 h for PHE and 6 and 12 h for LT) to obtain statistically significant results. Mitochondria purified from the liver of rats were immediately examined in the functional assay of cyt c release under the effect of 0.9 µM Ca²⁺ or 0.5 mM H₂O₂ and were further studied in Sandwich ELISA for the presence of various nAChR subunits. A similar ELISA assay was performed in the mitochondria-depleted liver fraction. The purity of mitochondrial and mitochondria-depleted preparations was characterized by ELISA using the antibodies against various intracellular compartments/organelles (Uspenska et al., 2017). As shown in **Figure 1**, the mitochondrial fraction was positive for mitochondria-specific marker VDAC (Colombini, 2004) and was negative for the nuclear-specific marker α-lamin

<figure><img src="image_3.png" /><figcaption>**FIGURE 1** | ELISA assay characterizing the purity of mitochondria (Mch) vs. mitochondria-depleted (non-Mch) rat liver fractions. Each column corresponds to mean ± SE, *n* = 3; *** *p* < 0.0005 compared to Mch fraction.</figcaption></figure>
<figure><img src="image_4.png" /></figure>

**FIGURE 2** | The changes in nAChR subunits content in the mitochondria (Mch) and mitochondria-depleted (non-Mch) liver fractions of rats subjected to PHE. (A,B) Absolute OD values, one rat per each time point; (C,D) normalized values for three rats per each time point compared to the section of the liver removed during hepatectomy (mean ± SE). \*p < 0.05; \*\*p < 0.005; \*\*\*p < 0.0005 compared to mitochondrial fraction.

B1 (Gruenbaum et al., 2000) and ER-specific marker IRE-1α (Chen and Brandizzi, 2013), while the mitochondria-depleted fraction, *vice versa*, was positive for lamin B1 and IRE-1α, but negative for VDAC. In contrast, the α7 nAChR content was similar in both fractions indicating its equal presence in either mitochondria or non-mitochondrial cell compartments. We did not use the markers of the plasma membrane assuming that plasma membrane nAChRs comprise only a small part (about 15%) of the whole intracellular pool (Sallette et al., 2005).

As shown in **Figure 2A**, an increase of α3, α7, and α9 nAChR subunits was observed in liver mitochondria already 3 h after hepatectomy reaching a maximum at 6 h. In contrast, in the liver fraction depleted of mitochondria, the decrease of corresponding subunits was found 3 h after surgery, while the peak increase was observed at the 6 h time point (**Figure 2B**). Later (12 and 24 h) the level of both mitochondrial and non-mitochondrial nAChRs was decreased reaching almost pre-operational state values. These data were confirmed with a statistically relevant number of animals for the 3 and 6 h time points and using a wider range of nAChR subunit-specific antibodies. As shown in **Figures 2C,D**, mitochondria up-regulated α3, α7, α9, α10, and β2 subunits at 3 h, whereas α7 and β2 subunits were decreased in the non-mitochondrial fraction at this time point. The α9 and α10 subunits were increased in both liver fractions. At 6 h, the increase of α4, α7, α9, β2, and β4 subunits was observed in the

non-mitochondria fraction and some β4 subunits appeared in mitochondria. These data suggested a redistribution of the liver nAChR pool in favor of mitochondria 3 h after hepatectomy followed by *de novo* nAChR synthesis at 6 h. Taking into account the established subunit combinations, these data indicate that the early stage of liver regeneration was accompanied by up-regulation of α3β2, α7β2, and α9α10 nAChR subtypes in mitochondria.

According to the data of functional assay, mitochondria of regenerating liver released less cyt c in response to Ca²⁺ or H₂O₂ 3 and 6 h after hepatectomy, while later there was no difference with the section of the liver removed during the hepatectomy (**Figure 3**). Therefore, up-regulated nAChR subtypes underlied mitochondria increased sustainability to apoptogenic stimuli.

A similar experimental schedule was applied for rats subjected to control surgery -LT. As shown in **Figure 4**, all nAChR subunits, except α9, were decreased in mitochondria 3 and 6 h after surgery, the restoration of α4, α7, and β2 was observed at 12 h only. In the mitochondria-depleted liver fraction, α4, α7, and β2 subunits were increased at 6 h already and, again, the main increase was found for α9 subunits, but not for α10 subunits. Therefore, LT was accompanied by the down-regulation of all liver nAChRs except α9-containing ones, which increased; the restoration of α4β2 and α7β2 nAChR subtypes started in the non-mitochondrial fraction 6 h after surgery.
<figure><img src="image_5.png" /><figcaption>**FIGURE 3** | Cyt c released from liver mitochondria of hepatectomized rats under the effect of either Ca²⁺ (0.9 µM) or H₂O₂ (0.5 mM). (A) Normalized data for one rat per each time point; (B) raw data for three rats per each time point; mean ± SE; \*p < 0.05; \*\*p < 0.0005 compared to pre-operation state (0 h).</figcaption></figure>

<figure><img src="image_6.png" /><figcaption>Fig 4</figcaption></figure>

<caption>**FIGURE 4** | The changes in nAChR subunits content in the mitochondria (Mch) and mitochondria-depleted (non-Mch) liver fractions of rats subjected to LT. (A,B) Absolute OD values, one rat per each time point; (C,D) normalized values for three rats per each time point compared to the section of the liver removed during hepatectomy (mean ± SE). \*p < 0.05; \*\*p < 0.005; \*\*\*p < 0.0005 compared to mitochondrial fraction.</caption>

In the functional assay, liver mitochondria of laparotomised rats released more cyt c in response to either Ca²⁺ or H₂O₂ 6 h after surgery compared to mitochondria of non-operated rats (Figure 5). These data indicated that LT initially made liver mitochondria more sensitive to apoptogenic influence and up-regulated α9 nAChRs were insufficient to fully compensate the decrease of other nAChR subtypes.

Therefore, the effect of LT was different from that of PHE indicating that different physiological processes were stimulated

by these two types of intervention. The only common feature was a significant increase of α9 nAChR subunits in both mitochondria and mitochondria-depleted fractions observed shortly after surgery. However, after PHE, the α9 up-regulation was accompanied by the increase of α10 subunits indicating the appearance of heteromeric α9α10 nAChRs, while after LT α9 subunits, most probably, were included in homomeric receptors.

The α-conotoxin PeIA is known to specifically target α9-containing nAChR subtypes (McIntosh et al., 2005).
<figure><img src="image_7.png" /><figcaption>**FIGURE 5** | Cyt c released from liver mitochondria of laparotomized rats under the effect of either Ca²⁺ (0.9 µM) or H₂O₂ (0.5 mM). (A) Normalized data for one rat per each time point; (B) raw data for three rats per each time point; mean ± SE; **p < 0.005 compared to pre-operation state (0 h).</figcaption></figure>

We compared the effect of α-conotoxin PeIA on mitochondria obtained from the section of the liver removed during the hepatectomy, regenerating liver and the liver after LT. As shown in **Figure 6**, α-conotoxin PeIA was poorly efficient in mitochondria of the liver removed during the hepatectomy and much more efficient in mitochondria of either PHE or LT liver, that was in accord with significant up-regulation of α9-containing nAChRs upon both types of surgery. In the Ca²⁺-stimulated cyt c release assay, α-conotoxin PeIA was more efficient in mitochondria from LT than PHE rats (50 vs. 30% of inhibition at 5nM, **Figure 6A**). However, when cyt c release was stimulated by H₂O₂, 25 nM conotoxin PeIA was more efficient in mitochondria from PHE than from LT rats (60 vs. 40% of inhibition, respectively, **Figure 6B**). Five nanomolar conotoxin PeIA was equally efficient against either Ca²⁺ or H₂O₂ in mitochondria of LT rats (about 50% of inhibition). Taking into account that (as shown above) PHE and LT resulted in up-regulation of different α9-containing nAChR subtypes in mitochondria, these data indicate that homomeric α9 receptors (LT) regulated both Ca²⁺- and H₂O₂-stimulated cyt c release from mitochondria, while activating α9α10 ones (PHE), with higher dose of α-conotoxin PeIA, attenuated preferentially H₂O₂-stimulated cyt c release.

## Mitochondria of α7-/-, α7β2-/-, and α3+/− Mice Up-Regulate α9 and β4 nAChR Subunits to Maintain Their Sustainability to Ca²⁺

The aim of this part of the study was to reveal if the absent nAChR subtypes are substituted with other ones in mitochondria of knockout animals and whether such substitution influences mitochondria sustainability to apoptogenic factors.

Sandwich ELISA assay with nAChR subunit-specific antibodies confirmed the absence of corresponding nAChR subunits in mitochondria of knockout mice and the decrease of α3 subunits in the α3+/− heterozygote (**Figure 7A**). The α4 subunits were down-regulated in the absence of either β2 or β4

subunits, and β2 subunits were down-regulated in the absence of α7 or the decrease of α3 subunits, thus confirming the presence of heteromeric α3β2, α4β2, and α7β2 nAChRs in mouse liver mitochondria. Most interestingly, the lack of α7, α7β2 or the decrease of α3 subunits resulted in significant up-regulation of α9 and β4 nAChR subunits.

To reveal the nAChR subtypes formed upon up-regulation of α9 and β4 subunits in mitochondria of knockout mice, we performed sandwich ELISA where the nAChR molecule was captured by one subunit-specific antibody and was detected with the antibody against another nAChR subunit. This assay has been developed in our laboratory and was successfully used to show the presence of α7β2 nAChRs in mitochondria and their substitution with α7β4 in the absence of the β2 subunit (Lykhmus et al., 2014). As shown in **Figure 7B**, the absence of α7 and β2 subunits resulted in up-regulation of α9α10, α3β4, and α4β4 subunit combinations. To our surprise, we also observed a clear signal for the α9β4 combination (in both antibody orientations) and its significant increase in mitochondria of α7β2-/- mice. These data demonstrated an intriguing possibility of α9β4 combination in mitochondria.

To study if the absence of any nAChR subtype affects mitochondria sustainability to Ca²⁺ we tested liver mitochondria of knockout mice in a cyt c release assay with increasing Ca²⁺ doses. As shown in **Figure 8**, mitochondria of all knockout mice released small amounts of cyt c even without Ca²⁺ addition. With low Ca²⁺ dose (0.1 µM), mitochondria of α7-/-, α7β2-/- and, to a lesser extent, α3+/− mice released more cyt c compared to mitochondria of WT mice. With 0.5 µM Ca²⁺, significant difference remained only for α7β2-/- mitochondria, and with 0.9 µM Ca²⁺, α7-/- and α7β2-/- mitochondria were even more resistant to Ca²⁺ than the WT ones. These data suggested that the nAChR subtypes expressed in mitochondria of knockout mice were less efficient against low, but more efficient against high Ca²⁺ doses compared to the nAChRs of the WT mitochondria.

Previously we reported that cyt c release from mitochondria can be inhibited by either α7-specific agonist PNU282987 or, to a lesser extent, antagonist methylicaconitine (MLA), as well as by
<figure><img src="image_8.png" /></figure>

**FIGURE 6** | The effect of α-conotoxin PeIA on Ca²⁺ (0.9 µM)-stimulated (A) or H₂O₂ (0.5 mM)-stimulated (B) cyt c release from mitochondria of non-operated (Ctrl), hepatectomized (PHE) or laparotomized (LT) rats 6 h after surgery. Each point corresponds to mean ± SE; *n* = 3; **p** < 0.005; ***p** < 0.0005 compared to corresponding PeIA concentration for non-operated rats mitochondria.

<figure><img src="image_9.png" /></figure>

**FIGURE 7** | The nAChR subunit composition (A) and subunit combinations (B) in mitochondria of the wild-type (WT) and α7β2-/- mice. Each column corresponds to mean ± SE, five mice per genotype; \*p < 0.05 compared to WT. The designations along abscissa correspond to the antibody combinations in sandwich ELISA: e.g., α9/β4 (α9-specific capture antibody and β4-specific detecting antibody) and β4/α9 (β4-specific capture antibody and α9-specific detecting antibody). \*\*p < 0.0005 compared to WT.

α4β2-specific DhβE or α3β2-specific α-conotoxin MII (Gergalova et al., 2014). When tested with nAChR subtype-specific ligands, cyt c release from mitochondria of α7-/- and α7β2-/- mice was not inhibited by PNU282987 and MLA, confirming the absence of α7-containing nAChRs. DhβE and conotoxin MII were less effective against α7β2-/- and α3+/- mitochondria, due to the absence/decrease of β2- and α3-containing nAChRs, respectively (Figure 9A).

To test whether α9-containing nAChRs, up-regulated in the absence of α7 nAChR subunits, are involved in regulating cyt c release from mitochondria, we compared the effect of α-conotoxin PeIA in mitochondria of the WT and α7-/- mice. As shown in Figures 9B,C, α-conotoxin PeIA inhibited cyt c release from mitochondria stimulated by 0.9 µM Ca²⁺ and, to a lesser extent, by 0.5 mM H₂O₂ and its effect against Ca²⁺ was much more efficient in mitochondria of α7-/- than of the WT mice. Therefore, α9-containing nAChRs up-regulated in the absence of α7-containing ones could functionally substitute them to support mitochondria resistance to Ca²⁺.

DISCUSSION

The data presented here demonstrate the significance of mitochondrial nAChRs for supporting liver cells viability in the course of PHE or in nAChR subunit-deficient mice.

Partial hepatectomy, when 70% of the organ is being resected, is a classical and well-characterized model of mammalian tissue regeneration. Extensive damage of liver parenchyma stimulates hepatic cells to transit from quiescence to proliferation with eventual restoration of liver mass and function (Michalopoulos, 2010; Fausto et al., 2012). The consequence of events following PHE is well established. The first, priming phase of regeneration occurs during 3 h after surgery, while the DNA synthesis starts after 11-12 h (Kountouras et al., 2001). The initial period of regeneration is accompanied by inhibition of apoptosis and improving the survival rate of hepatocytes, usually attributed to the effect of transcription factors NFkB and STAT and inhibition of caspases 3 and 8 (Tarlá et al., 2006). We observed the increase of nAChR protein in liver mitochondria 3 h after PHE
accompanied by decreased release of cyt c in response to either Ca²⁺ or H₂O₂ compared to mitochondria of intact liver. Instead, α7 and β2 subunits were decreased in mitochondria-depleted fraction during the priming phase of liver regeneration, starting to increase only after 6 h. This means that, after hepatectomy, the available nAChRs are targeted mainly to mitochondria and then the intracellular pool of nAChRs is replenished by *de novo* synthesis. By 12 h, the start of proliferative phase, the levels of nAChRs and cyt c released return to almost pre-operative state.

<figure><img src="image_10.png" /></figure>

**FIGURE 8** | Cyt c release from mitochondria of the wild-type (WT) or knockout mice in response to different Ca²⁺ doses. Each column corresponds to mean ± SE, five mice per genotype; \*p < 0.05; \#p < 0.0005 compared to WT.

The properties of mitochondria during liver regeneration following PHE have been extensively studied. According to the literature data, in the early (pre-replicative) phase of liver regeneration, mitochondria ultrastructure is changed significantly: a number of mitochondria with dilated, paled and vacuolized matrix could be observed. The activities of Complex I+III, Complex II+III and Complex IV all decreased drastically at 6 h after hepatectomy and then gradually returned to the original level during 18–24 h (Tsai *et al.*, 1992). The isolated mitochondria showed impairment in membrane permeability properties, an increase in Ca²⁺ content and the release of proteins, like aspartate aminotransferase and glutamic acid degydrogenase, from the matrix (Zhou *et al.*, 2008). This suggests the occurrence in the early phase of liver regeneration of a transient mitochondrial oxidative stress accompanied with the changes in mitochondria ultrastructure. The mitochondrial ultrastructure, the membrane permeability properties and the Ca²⁺ content returned to normal values during the replicative phase of liver regeneration when a progressive recovery of liver mass is observed (Guerrieri *et al.*, 2002). These data fit well with our observation showing the return of mitochondrial nAChR content to pre-operative state at 12 h after PHE. Despite alteration in mitochondrial membrane permeability properties, no release of cyt c was found during the prereplicative phase of liver regeneration (Guerrieri *et al.*, 2002). This data indirectly confirm the stabilizing role of mitochondrial nAChRs during the critical period (3 and 6 h after PHE) when the remaining liver cells should be kept alive, as shown in our experiments.

Laparotomy does not damage the liver but includes stress reaction and local inflammation caused by the surgery (Markiewski *et al.*, 2006). In contrast to PHE, all mitochondrial

<figure><img src="image_11.png" /></figure>

**FIGURE 9** | The effect of PNU 282987 (1 µM), MLA (50 nM), DhβE (1 µM), and α-conotoxin MII (1 nM) (A) or α-conotoxin PeIA (B,C) on Ca²⁺ (0.9 µM)-stimulated (A,B) and H₂O₂ (0.5 mM)-stimulated (C) cyt c release from mitochondria of the wild-type (WT) and knockout mice. Each column (A) or point (B,C) corresponds to mean ± SE, three to five mice per genotype; \*p < 0.05; \*\*p < 0.005; \*\*\*p < 0.0005 compared to WT.
nAChR subunits, except α9, were decreased 3 and 6 h after LT. Consequently, liver mitochondria released more cyt c in response to either Ca²⁺ or H₂O₂ at 6 h time point.

These data clearly indicate that mitochondrial nAChRs are dramatically important during the initial phase of liver regeneration to support the survival of hepatic cells, but not their proliferation occurring later. In contrast, they are not involved in acute stress reaction when the liver is not damaged.

The importance of mitochondrial nAChRs was further confirmed in experiments with knockout mice, indicating that the absence or deficiency of α3-, α7-, or β2-containing nAChRs is compensated by α3β4, α4β4, α9α10, and α9β4 nAChR subtypes. Compared to α7β2 and α3β2 nAChRs, present in WT mitochondria, the compensating ones appeared to be less efficient against low but more efficient against high Ca²⁺ doses and, therefore, are expected to control the more severe apoptogenic challenges compared to those of the WT mice.

The data obtained in both knockout mice and operated rats allow discussing the impact of different nAChR subtypes in supporting mitochondria sustainability to apoptogenic stimuli. First of all, this concerns the α9- and β4-containing nAChRs, which are up-regulated in response to either nAChRs deficiency or tissue damage.

The α9 subunit belongs to the most ancient branch of nAChR genes evolutionary tree (Ortells and Lunt, 1995). Initially, the α9-containing nAChRs were found in the hair cells of the inner ear (Elgoyhen et al., 1994), but were further determined in many non-excitable cells (Chernyavsky et al., 2007; Colomer et al., 2010), the neurons of the dorsal root ganglia (Lips et al., 2002), the brain (Lykhmus et al., 2017), and mitochondria (Chernyavsky et al., 2007; Uspenska et al., 2017). The α9 subunits can contribute to both homomeric and heteromeric nAChRs (Plazas et al., 2005). In addition to previously described α9α10 combination, our data allow suggesting the presence of α9β4* nAChRs in the liver mitochondria of α7-/– and α7β2-/– mice. Taking into account that mitochondrial nAChRs do not function as ion channels (Gergalova et al., 2014), one can assume that mitochondria may contain the non-conventional nAChR subunit combinations, which do not form functional ion channels when expressed in the plasma membrane. However, this question, as well as the function and ligand specificity of α9β4 nAChRs, needs further examination. The up-regulation of α9 subunits was observed in keratinocytes (Chernyavsky et al., 2007), B-lymphocytes (Koval et al., 2011) and the brain of α7-/– mice (Lykhmus et al., 2017) that is in accord with our data.

A fast and dramatic increase of α9 nAChR subunits in the liver of both hepatectomized and laparotomized rats was, evidently, due to translation of available RNA messages. A large amount of α9 RNA was found in lymphocytes (Peng et al., 2004; Hao et al., 2011; Qian et al., 2011), although the α9 protein content was quite moderate (Koval et al., 2011). Therefore, it seems that this ancient alpha subunit is kept as a reserve and its amount can be quickly increased in response to environmental challenges, like stress or pain caused by the surgery. The α9-containing nAChRs were regarded as the targets to treat the chronic pain (Vincler and McIntosh, 2007; McIntosh et al., 2009); therefore, their up-regulation may be related to the pain reaction, which cannot be

completely excluded in spite of an ether narcosis and analgesics used in our experiments.

The increase of α9-containing nAChRs in mitochondria of both operated rats and knockout mice resulted in their increased sensitivity to α-conotoxin PeIA. Interestingly, α-conotoxin PeIA affected mainly Ca²⁺-stimulated cyt c release in mitochondria of α7-/– mice, H₂O₂-stimulated cyt c release in mitochondria of hepatectomized rats and both in mitochondria of laparotomized rats. Previously we reported that Ca²⁺ or H₂O₂ induce cyt c release from mitochondria through different signaling pathways (Gergalova et al., 2014). The data presented here allow suggesting that α-conotoxin PeIA influenced non-identical pathways through α9α10 nAChRs (PHE), α9β4* nAChRs (α7-/– mice) or homomeric α9 nAChRs (LT). In general, the ability of α9* nAChRs to control various pathways demonstrates the universal nature of this ancient nAChR subtype that explains its urgent up-regulation in critical circumstances. The involvement of additional subunits seems to influence the signaling capacity of α9 homopentamer depending on the demand.

The up-regulation of β4-containing nAChRs was observed in mitochondria of α3+/–, α7-/–, and α7β2-/– mice. In these non-conditional knockouts, corresponding subunits are absent from the very beginning and, therefore, expression of other nAChR subunit genes can be regarded as a compensatory reaction.

The nature of beta subunits (β2 vs. β4) has been shown to influence the kinetic properties and agonist specificity of both α3-containing (Papke and Heinemann, 1991) and α4-containing nAChRs (Houlihan et al., 2001). Moreover, it was found that α3α5β4 nAChRs possess substantial Ca²⁺ permeability, comparable to that of α7 nAChRs (Lax et al., 2002). The β4-containing nAChRs are mainly expressed in autonomic ganglia neurons (Skok, 2002; Del Signore et al., 2004) and in certain brain areas (Grady et al., 2009), while, up to our knowledge, there is no information about their presence in non-excitable tissues. Here we show that the β4 subunit is expressed in the liver in the absence of α7, α3, or β2 nAChR subunits. However, since mitochondrial nAChRs were shown to function in an ion channel-independent manner (Gergalova et al., 2014), it is not clear whether the channel properties of β4-containing nAChRs may play a role.

Recently we reported that liver mitochondria of α7-/– mice become more sensitive to the non-competitive antagonist of α3β4* nAChRs (±)-18-methoxycoronaridine (18-MC) compared to mitochondria of the WT mice (Arias et al., 2015, 2018). Moreover, it was found that 18-MC, which affected mainly H₂O₂-stimulated cyt c release in mitochondria of the WT mice, became more efficient against Ca²⁺ in mitochondria of α7-/– mice. It was concluded that α3β4* nAChRs, up-regulated in the absence of α7-containing nAChRs, take their functional role to regulate Ca²⁺-stimulated apoptogenic events. Probably, α9β4* nAChRs, which appear in the absence of α7 subunits, are also intended to compensate the deficiency of CaKMII-dependent regulation in mitochondria. Previously, we observed a significant (several fold) up-regulation of β4 subunits in the brain mitochondria of α9-/– mice (Lykhmus et al., 2017). In contrast, as shown here, no significant changes were observed
in β4-/– mitochondria, suggesting that in the WT mice its
amount and function are negligible. Therefore, it seems that,
along with the α9 subunit, the β4 one is a universal compensatory
subunit, which starts to be expressed in mitochondria in the
absence of α3, α7, α9, or β2 nAChR subunits and ensures
the coupling of mitochondrial nAChRs to CaKMII-dependent
signaling pathway.

CONCLUSION

In conclusion, the two models used demonstrate the importance
of mitochondrial nAChRs for supporting the viability of liver
cells. The mitochondrial α3β2, α7β2, and α9α10 nAChRs are
up-regulated during the priming phase of liver regeneration
after PHE, and the absence or decrease of α7, β2, or α3
subunits in knockout mice are compensated by up-regulation
of α3β4, α4β4, α7β4, α9β4, and α9α10 nAChRs to support
the mitochondria resistance to apoptogenic influence. The
α9 subunits are universal “reserve” ones, which are up-
regulated both upon deficiency of other nAChR subtypes (in
knockout animals) and in response to stress caused by tissue
damage. Depending on the demand, they may be included
in either homo- or hetero-meric receptors containing either
α10 or β4 auxiliary subunits that underlies their involvement
in intramitochondrial signaling. The β4 subunits start to
be expressed in the absence of α7, β2, or α3 subunits to
compensate the deficiency of mitochondrial CaKMII-dependent
signaling. The concerted action of multiple nAChR subtypes
controlling different signaling pathways in mitochondria ensures
a reliable protection against apoptogenic factors of different
nature.

Of course, the efficacy of anti-apoptotic protection depends
not only on the quantity and subtypes of mitochondrial nAChR,
but also on the availability of their natural ligands. The α7-
containing nAChRs can be activated by choline, which is
abundant in the cytosole and around mitochondria. In contrast,
other nAChR subtypes require the presence of acetylcholine,

which can be formed from choline by mitochondrial choline
acetyltransferase (Pagliarini et al., 2008). Whether the quantity of
intracellular acetylcholine or ChAT activity are altered in α7-/–
mice and during PHE or LT is unknown and may be a subject
of future studies. Consequently, mitochondrial nAChRs may be
regarded as a promising pharmacological target for the therapy
supporting the cell survival.

AUTHOR CONTRIBUTIONS

MS, MO, SK, and UM made substantial contributions to the conception or design of the work. KU, OL, MO, SP, and MS contributed to acquisition, analysis, and interpretation of data for the work. MS contributed to drafting the manuscript. KU, OL, MO, SK, and UM contributed to revising the manuscript critically for important intellectual content. KU, OL, MO, SP, UM, SK, and MS approved the final version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

FUNDING

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The part of experiments performed in Institut Pasteur was supported by the FEBS Collaborative Experimental Scholarships for Central & Eastern Europe (KU).

ACKNOWLEDGMENTS

We are grateful to Prof. O. Minchenko for providing IRE-1-
specific antibody, to Prof. T. Kuchmerovskaya for lamin-B1-
specific antibody, to Prof. W. Kummer for α10-specific antibody,
and to Prof V. Tsetlin for conotoxin PeIA.

REFERENCES

Arias, H. R., Feuerbach, D., Targowska-Duda, K. M., and Jozwiak, K. (2015). Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites. *Int. J. Biochem. Cell Biol.* 65, 81–90. doi: 10.1016/j.neuint.2017.12.008

Arias, H. R., Lykhmus, O. Y., Uspenska, K. R., and Skok, M. V. (2018). Coronaridine congeners modulate mitochondrial α3β4 nicotinic acetylcholine receptors. *Neurochem. Int.* 114, 26–32.

Bocquet, N., Prado de Carvalho, L., Cartaud, J., Neyton, J., Le Poupon, C., Taly, A., et al. (2007). A prokaryotic proton-gated ion channel from the nicotinic acetylcholine receptor family. *Nature* 445, 116–119. doi: 10.1038/nature05371

Changeux, J. P. (2012). The nicotinic acetylcholine receptor: the founding father of the pentameric ligand-gated ion channel superfamily. *J. Biol. Chem.* 287, 40207–40215. doi: 10.1074/jbc.R112.407668

Chen, Y., and Brandizzi, F. (2013). IRE1: ER stress sensor and cell fate executor. *Trends Cell Biol.* 23, 547–555. doi: 10.1016/j.tcb.2013.06.005

Chernyavsky, A. I., Arredondo, J., Vetter, D. E., and Grando, S. A. (2007). Central role of alpha9 acetylcholine receptor in coordinating keratinocyte adhesion and

motility at the initiation of epithelialization. *Exp. Cell Res.* 313, 3542–3555.
doi: 10.1016/j.yexcr.2007.07.011

Colombini, M. (2004). VDAC: the channel at the interface between mitochondria and the cytosol. *Mol. Cell. Biochem.* 256/257, 107–115. doi: 10.1023/B:MCBI.0000009862.17396.8d

Colomer, C., Olivos-Oré, L. A., Vincent, A., McIntosh, J. M., Artalejo, A. R., and Guérineau, N. C. (2010). Functional characterization of alpha9-containing cholinergic nicotinic receptors in the rat adrenal medulla: implication in stress-induced functional plasticity. *J. Neurosci.* 30, 6732–6742. doi: 10.1523/JNEUROSCI.4997-09.2010

Cormier, A., Morin, C., Zini, R., Tillement, J. P., and Lagrue, G. (2001). In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation. *Brain Res.* 900, 72–79. doi: 10.1016/S0006-8993(01)02254-5

Del Signore, A., Gotti, C., Rizzo, A., Moretti, M., and Paggi, P. (2004). Nicotinic acetylcholine receptor subtypes in the rat sympathetic ganglion: pharmacological characterization, subcellular distribution and effect of pre- and postganglionic nerve crush. *J. Neuropathol. Exp. Neurol.* 63, 138–150. doi: 10.1093/jnen/63.2.138

Elgoyhen, A. B., Johnson, D. S., Boulter, J., Vetter, D. E., and Heinemann, S. (1994). Alpha 9: an acetylcholine receptor with novel pharmacological properties
expressed in rat cochlear hair cells. *Cell* 79, 705-715. doi: 10.1016/0092-8674(94)90555-X

Fausto, N., Campbell, J. S., and Riehle, K. J. (2012). Liver regeneration. *J. Hepatol*. 57, 692-694. doi: 10.1016/j.jhep.2012.04.016

Gergalova, G., Lykhmus, O., Komisarenko, S., and Skok, M. (2014). α7 Nicotinic acetylcholine receptors control cytochrome c release from isolated mitochondria through kinase-mediated pathways. *Int. J. Biochem. Cell Biol.* 49, 26-31. doi: 10.1016/j.biocel.2014.01.001

Gergalova, G. L., Lykhmus, O., Kalashnyk, O. M., Koval, L. M., Chernyshov, V. O., Kryukova, E. A., et al. (2012). Mitochondria express α7 nicotinic acetylcholine receptors to regulate Ca2+ accumulation and cytochrome c release: study on isolated mitochondria. *PLoS One* 7:e31361. doi: 10.1371/journal.pone.0031361

Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., et al. (2009). Structural and functional diversity of native brain neuronal nicotinic receptors. *Biochem. Pharmacol.* 78, 703-711. doi: 10.1016/j.bcp.2009.05.024

Grady, S. R., Moretti, M., Zoli, M., Marks, M. J., Zanardi, A., Pucci, L., et al. (2009). Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the α3β4* and α3β3β4* subtypes mediate acetylcholine release. *J. Neurosci.* 29, 2272-2282. doi: 10.1523/JNEUROSCI.5121-08.2009

Grando, S. A. (2014). Connections of nicotine to cancer. *Nat. Rev. Cancer* 14, 419-429. doi: 10.1038/nrc3725

Gruenbaum, Y., Wilson, K. L., Harel, A., Goldberg, M., and Cohen, M. (2000). Review: nuclear lamins - structural proteins with fundamental functions. *J. Struct. Biol.* 129, 313-323. doi: 10.1006/jsbi.2000.4216

Guerrieri, F., Pellechia, G., Lopriore, B., Papa, S., Esterina, Liquori G, Ferri, D., et al. (2002). Changes in ultrastructure and the occurrence of permeability transition in mitochondria during rat liver regeneration. *Eur. J. Biochem.* 269, 3304-3312. doi: 10.1046/j.1432-1033.2002.03010.x

Hao, J., Simard, A. R., Turner, G. H., Wu, J., Whiteaker, P., Lukas, R. J., et al. (2011). Attenuation of CNS inflammatory responses by nicotine involves α7 and non-α7 nicotinic receptors. *Exp. Neurol.* 227, 110-119. doi: 10.1016/j.expneurol. 2010.09.020

Harlow, E., and Lane, D. (1988). *Antibodies. A Laboratory Manual*. New York, NY: Cold Spring Harbor Laboratory, 341-342.

Higgins, G. M., and Anderson, R. M. (1931). Experimental pathology of the liver I. Restoration of the liver of white rat following partial surgical removal. *Arch. Pathol.* 12, 186-202.

Houlihan, L. M., Slater, Y., Guerra, D. L., Peng, J. H., Kuo, Y. P., Lukas, R. J., et al. (2001). Activity of cytisine and its brominated isosteres on recombinant human alpha7, alpha4beta2 and alpha4beta4 nicotinic acetylcholine receptors. *J. Neurochem.* 78, 1029-1043. doi: 10.1046/j.1471-4159.2001.00481.x

Kalamida, D., Poulas, K., Avramopoulou, V., Fostieri, E., Lagoumintzis, G., Lazaridis, K., et al. (2007). Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity. *FEBS J.* 274, 3799-3845. doi: 10.1111/j.1742-4658.2007.05935.x

Kawashima, K., and Fujii, T. (2008). Basic and clinical aspects of non-neuronal acetylcholine: overview of non-neuronal cholinergic systems and their biological significance. *J. Pharmacol. Sci.* 106, 167-173. doi: 10.1254/jphs. FM0070073

Kountouras, J., Boura, P., and Lygidakis, N. J. (2001). Liver regeneration after hepatectomy. *Hepatogastroenterology* 48, 556-562.

Koval, L., Lykhmus, O., Zhmak, M., Khruschov, A., Tsetlin, V., Magrini, E., et al. (2011). Differential involvement of α4β2, α7 and α9α10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro. *Int. J. Biochem. Cell Biol.* 43, 516-524. doi: 10.1016/j.biocel.2010.12.003

Koval, O. M., Voitenko, L. P., Skok, M. V., Lykhmus, E. Y., Tsetlin, V. I., Zhmak, M. N., et al. (2004). The (-subunit composition of nicotinic acetylcholine receptors in the neurons of the guinea pig inferior mesenteric ganglion. *Neurosci. Lett.* 365, 143-146. doi: 10.1016/j.neulet.2004.04.071

Lax, P., Fucile, S., and Eusebi, F. (2002). Ca2+ permeability of human heteromeric nAChRs expressed by transfection in human cells. *Cell Calcium* 32, 53-58. doi: 10.1016/S0143-4160(02)00076-3

Lips, K. S., Pfeil, U., and Kummer, W. (2002). Coexpression of (9 and (10 nicotinic acetylcholine receptors in rat dosal root ganglion neurons. *Neuroscience* 115, 1-5. doi: 10.1016/S0306-4522(02)00274-9

Lykhmus, O., Gergalova, G., Koval, L., Zhmak, M., Komisarenko, S., and Skok, M. (2014). Mitochondria express several nicotinic acetylcholine receptor subtypes

to control various pathways of apoptosis induction. *Int. J. Biochem. Cell Biol.* 53, 246-252. doi: 10.1016/j.biocel.2014.05.030

Lykhmus, O., Gergalova, G., Zouridakis, M., Tzartos, S., Komisarenko, S., and Skok, M. (2015). Inflammation decreases the level of alpha7 nicotinic acetylcholine receptors in the brain mitochondria and makes them more susceptible to apoptosis induction. *Int. Immunopharmacol.* 29, 148-151. doi: 10.1016/j.intimp.2015.04.007

Lykhmus, O., Koval, L., Pavlovych, S., Zouridakis, M., Zisimopoulou, P., Tzartos, S., et al. (2010). Functional effects of antibodies against non-neuronal nicotinic acetylcholine receptors. *Immunol. Lett.* 128, 68-73. doi: 10.1016/j.imlet.2009. 11.006

Lykhmus, O., Mishra, N., Koval, L., Kalashnyk, O., Gergalova, G., Uspenska, K., et al. (2016). Molecular mechanisms regulating LPS-induced inflammation in the brain. *Front. Mol. Neurosci.* 9:19. doi: 10.3389/fnmol.2016.00019

Lykhmus, O., Voytenko, L., Lips, K. S., Bergen, I., Krasteva-Christ, G., Vetter, D. E., et al. (2017). Nicotinic acetylcholine receptor α9 and α10 subunits are expressed in the brain of mice. *Front. Cell Neurosci.* 11:282. doi: 10.3389/fncel.2017. 00282

Markiewski, M. M., DeAngelis, R. A., and Lambris, J. D. (2006). Liver inflammation and regeneration: two distinct biological phenomena or parallel pathophysiologic processes? *Mol. Immunol.* 43, 45-56. doi: 10.1016/j.molimm. 2006.06.019

McIntosh, J. M., Absalom, N., Chebib, M., Elgoyhen, A. B., and Vincler, M. (2009). Alpha9 nicotinic acetylcholine receptors and the treatment of pain. *Biochem. Pharmacol.* 78, 693-702. doi: 10.1016/j.bcp.2009.05.020

McIntosh, J. M., Plazas, P. V., Watkins, M., Gomez-Casati, M. E., Olivera, B. M., and Elgoyhen, A. B. (2005). A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors. *J. Biol. Chem.* 280, 30107-30112. doi: 10.1074/ jbc.M504102200

Michalopoulos, G. K. (2010). Liver regeneration after partial hepatectomy. Critical analysis of mechanistic dilemmas. *Am. J. Pathol.* 176, 2-13. doi: 10.2353/ajpath. 2010.090675

Orr-Urtreger, A., Goldner, F. M., Saeki, M., Lorenzob, I., Goldberg, L., De Biasi, M., et al. (1997). Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack α-bungarotoxin binding sites and hippocampal fast nicotinic currents. *J. Neurosci.* 17, 9165-9171. doi: 10.1523/JNEUROSCI.17-23-09165. 1997

Ortells, M., and Lunt, G. (1995). Evolutionary history of the ligand-gated ion channel superfamily of receptors. *Trends Neurosci.* 18, 121-127. doi: 10.1016/ 0166-2236(95)93887-4

Pagliarini, D. J., Calvo, S. E., Chang, B., Sheth, S. A., Vafai, S. B., Ong, S. E., et al. (2008). A mitochondrial protein compendium elucidates complex I disease biology. *Cell* 134, 112-123. doi: 10.1016/j.cell.2008.06.016

Papke, R. L., and Heinemann, S. F. (1991). The role of the beta 4-subunit in determining the kinetic properties of rat neuronal nicotinic acetylcholine alpha 3-receptors. *J. Physiol.* 440, 95-112. doi: 10.1113/jphysiol.1991.sp018698

Peng, H., Ferries, R. L., Matthews, T., Hiel, H., Lopez-Albaitero, A., and Lustig, L. R. (2004). Characterization of the human nicotinic acetylcholine receptor subunit alpha9 (CHRNA9) and alpha10 (CHRNA10) in lymphocytes. *Life Sci.* 76, 263-280. doi: 10.1016/j.lfs.2004.05.031

Plazas, P. V., Katz, E., Gomez-Casati, M. E., Bouzat, C., and Elgoyhen, A. B. (2005). Stoichiometry of the alpha9alpha10 nicotinic cholinergic receptor. *J. Neurosci.* 25, 10905-10912. doi: 10.1523/JNEUROSCI.3805-05.2005

Qian, J., Galitovskiy, V., Chernyavsky, A. I., Marchenko, S., and Grando, S. A. (2011). Plasticity of the murine spleen T-cell cholinergic receptors and their role in in vitro differentiation of naïve CD4 T cells toward the Th1, Th2 and Th17 lineages. *Genes Immun.* 12, 222-230. doi: 10.1038/gene.2010.72

Sallette, J., Pons, S., Devillers-Thiery, A., Soudant, M., Prado de Carvalho, L., Changeux, J. P., et al. (2005). Nicotine upregulates its own receptors through enhanced intracellular maturation. *Neuron* 46, 595-607. doi: 10.1016/j.neuron. 2005.03.029

Skok, M., Gergalova, G., Lykhmus, O., Kalashnyk, O., Koval, L., and Uspenska, K. (2016). Nicotinic acetylcholine receptors in mitochondria: subunit composition, function and signalling. *Neurotransmitter* 3:e1290.

Skok, M. V. (2009). To channel or not to channel? Functioning of nicotinic acetylcholine receptors in leukocytes. *J. Leukocyte Biol.* 86, 1-3. doi: 10.1189/ jlb.0209106
Skok, M. V., Voitenko, L. P., Voitenko, S. V., Lykhmus, E. Y., Kalashnik, E. N., Litvin, T. I., et al. (1999). Alpha subunit composition of nicotinic acetylcholine receptors in the rat autonomic ganglia neurons as determined with subunit-specific anti-alpha(181-192) peptide antibodies. Neuroscience 93, 1427-1436. doi: 10.1016/S0306-4522(99)00160-8

Skok, V. I. (2002). Nicotinic acetylcholine receptors in autonomic ganglia. *Auton. Neurosci.* 97, 1-11. doi: 10.1016/S1566-0702(01)00386-1

Sottocasa, G. L., Kuylenstierna, B., Ernster, L., and Bergstrand, A. (1967). An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. *J. Cell Biol.* 32, 415-438. doi: 10.1083/jcb.32.2.415

Surin, A. M., Kriukova, E. V., Strukov, A. S., Zhmak, M. N., Talka, R., Tuominen, R., et al. (2012). [Effect of alpha-conotoxin MII and its N-terminal derivatives on Ca2+ and Na+ signals induced by nicotine in neuroblastoma cell line SH-SY5Y]. *Bioorg. Khim.* 38, 214-222.

Tannuri, A. C., Tannuri, U., Coelho, M. C., Santos, N. A., and Mello, E. S. (2007). Experimental models of hepatectomy and liver regeneration using newborn and weaning rats. *Clinics* 62, 757-762. doi: 10.1590/S1807-593220070006 00016

Tarlá, M. R., Ramalho, F. S., Ramalho, L. N., Silva, Tde, C., Brandão, D. F., et al. (2006). A molecular view of liver regeneration. *Acta Cir. Bras.* 21(Suppl. 1), 58-62. doi: 10.1590/S0102-865020060007000014

Tsai, J. L., King, K. L., Chang, C. C., and Wei, Y. H. (1992). Changes of mitochondrial respiratory functions and superoxide dismutase activity during liver regeneration. *Biochem. Int.* 28, 205-217.

Uspenska, K., Lykhmus, O., Gergalova, G., Chernyshov, V., Arias, H. R., Komisarenko, S., et al. (2017). Nicotine facilitates nicotinic acetylcholine receptor targeting to mitochondria but makes them less susceptible to selective ligands. *Neurosci. Lett.* 656, 43-50. doi: 10.1016/j.neulet.2017.07.009

Vincler, M., and McIntosh, J. M. (2007). Targeting the alpha9alpha10 nicotinic acetylcholine receptor to treat severe pain. *Expert Opin. Ther. Targets* 11, 891-897. doi: 10.1517/14728222.11.7.891

Wessler, I., and Kirkpatrick, C. J. (2008). Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. *Br. J. Pharmacol.* 154, 1558-1571. doi: 10.1038/bjp.2008.185

Xu, W., Gelber, S., Orr-Urtreger, A., Armstrong, D., Lewis, R. A., Ou, C. N., et al. (1999a). Megacystis, mydriasis, and ion channel defect in mice lacking the α3 neuronal nicotinic acetylcholine receptor. *Proc. Natl. Acad. Sci. U.S.A.* 96, 5746-5751.

Xu, W., Orr-Urtreger, A., Nigro, F., Gelber, S., Sutcliffe, C. B., Armstrong, D., et al. (1999b). Multiorgan autonomic dysfunction in mice lacking the β2 and the β4 subunits of neuronal nicotinic acetylcholine receptors. *J. Neurosci.* 19, 9298-9305. doi: 10.1523/JNEUROSCI.19-21-09298.1999

Zhou, Y. H., Shi, D., Yuan, B., Sun, Q. J., Jiao, B. H., and Sun, J. J. (2008). Mitochondrial ultrastructure and release of proteins during liver regeneration. *Indian J. Med. Res.* 128, 157-164.

**Conflict of Interest Statement:** The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2018 Uspenska, Lykhmus, Obolenskaya, Pons, Maskos, Komisarenko and Skok. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.